Crescendo Biologics develops potent, multi-functional Humabody® therapeutics with a focus on novel targeted T-cell engagement. Using our proprietary transgenic mouse platform, we have created a tumour-targeted T-cell engager mechanism capable of activating T-cells only in the tumour microenvironment. Our ability to configure unique therapeutic formats allows Humabodies to engage targets in ways that generates new biology thro...
Crescendo Biologics develops potent, multi-functional Humabody® therapeutics with a focus on novel targeted T-cell engagement. Using our proprietary transgenic mouse platform, we have created a tumour-targeted T-cell engager mechanism capable of activating T-cells only in the tumour microenvironment. Our ability to configure unique therapeutic formats allows Humabodies to engage targets in ways that generates new biology through novel target engagement. Our transgenic VH platform enables us to create an almost limitless number of mono- and multi-functional constructs capable of engaging therapeutically valuable targets.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.